ArticleDrugs - real world outcomes2020

Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience.

Lauren E Brownell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.